These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32768698)

  • 1. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
    Brito-Azevedo A
    Int J Infect Dis; 2020 Oct; 99():324. PubMed ID: 32768698
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
    Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
    J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.
    Parra-Lara LG; Martínez-Arboleda JJ; Rosso F
    J Glob Antimicrob Resist; 2020 Sep; 22():680-684. PubMed ID: 32622008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
    Fanin A; Calegari J; Beverina A; Tiraboschi S;
    Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 7. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
    Lebeaux D; Revest M
    Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
    Popescu CP; Fischer PR
    Travel Med Infect Dis; 2020; 35():101764. PubMed ID: 32485391
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
    Bonow RO; Hernandez AF; Turakhia M
    JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
    [No Abstract]   [Full Text] [Related]  

  • 10. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Li C; Cheng G
    Front Immunol; 2020; 11():1969. PubMed ID: 32849658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
    Pothen L; Yildiz H; De Greef J; Penaloza A; Beauloye C; Belkhir L; Yombi JC
    Travel Med Infect Dis; 2020; 36():101788. PubMed ID: 32540396
    [No Abstract]   [Full Text] [Related]  

  • 12. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
    Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 15. Auditory Cinchonism in COVID Era.
    Saniasiaya J; Kulasegarah J
    Ear Nose Throat J; 2020 Nov; 99(9):597-598. PubMed ID: 32744901
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
    Bonny A; Talle MA; Ngantcha M; Tayebjee MH
    Travel Med Infect Dis; 2020; 37():101861. PubMed ID: 32889105
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
    Atkinson JG
    Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Farfán-López M; Espinoza-Culupú A
    Rev Peru Med Exp Salud Publica; 2020; 37(2):383-384. PubMed ID: 32876237
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
    Rosendaal FR
    Int J Antimicrob Agents; 2020 Jul; 56(1):106063. PubMed ID: 32674928
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
    Mazzitelli M; Davoli C; Scaglione V; Fusco P; La Gamba V; Matera G; Trecarichi EM; Torti C
    Travel Med Infect Dis; 2020; 37():101826. PubMed ID: 32739472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.